Welcome to BioSeeker Group!

Target Atlas in Oncology Drug Development: Targeted Therapies

Additional Information

Published on Date Multi-report (See individual release dates)
Format PDF
Publisher BioSeeker Group

Availability: In stock

$5,750.00

Quick Overview

This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances.

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to Target Atlas in Oncology Drug Development: Targeted Therapies.

    To find out more about Target Atlas in Oncology Drug Development: Targeted Therapies, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that Target Atlas in Oncology Drug Development: Targeted Therapies is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

With the emergence of new technologies and an increased understanding of the biological basis for cancer evolution, the molecular changes that distinguish malignant-cells from normal cells are becoming increasingly apparent, offering a growing range of potential drug targets in the form of altered genes, proteins or corrupted pathways. Drug targets are the critical link between drugs and their role in the treatment of medical disorders.

This report, Target Atlas in Oncology Drug Development: Targeted Therapies, is written for you to identify your competition and understand which targeting strategies are at work within the cancer drug development landscape. It allows you to pin-point which competitors drugs’ clinical out-come may have bearing on your own drug development and who are developing sequels to successful drugs. This report also helps you to locate white-spots in the competitive landscape, giving you little or no competition. Conversely it may reveal unexpected competition for you.

Target Atlas in Oncology Drug Development: Targeted Therapies is a multi-report made up by five different and independent target reports covering targeted therapies:

Targeted Therapy Strategies in Cancer
Apoptosis

Angiogenesis/VDA/VTA

Antibodies

Immunomodulators & Vaccines

Protein Kinase Inhibitors

Each report subject (click on each subject for detailed information) covers:

  • Compound strategies based on sub-cellular localization of cancer drug targets
  • The Cancer Genome Project and cancer drug targets
  • Expression levels of identified drug targets in selected tumor type
  • Pathway analysis of cancer drug targets
  • Target-target interactions among identified cancer targets
  • Structure-based drug design in ïs stimulated by available structure data on biological targets
  • Unique, in-depth, drug target validating profiles, highlighting twelve themes about the drug target, i.e. protein-protein interaction with other cancer drug targets, pursued cancer indications, drugs under development, presence in the Cancer Genome Project etc.
  • Drug-target interactome
  • The progression and maturity of cancer targets: New and unique cancer drug targets
  • Targeted therapy specific reports deal with all drug targets by cancer indication.
  • Cancer drug target profiles by investigator

This report is an open landscape of resources to build, fuel, and drive your scientific competitive vehicle for the advancement of cancer drugs. It will assist you in lead commercial analysis and product strategy thinking to build and nurture current and future portfolio of drug candidates and R&D alliances. This report will help you to streamline your analysis of new as well as of established drug targets, when looking for clinical proofs, indication selection, competitive environment etc.

Alternative Versions of this Report:

  • Complete Target Atlas in Oncology Drug Development: From Tumor to Targeted Therapy
  • Target Atlas in Oncology Drug Development: Major Tumor Types
  • Triple Target Atlas in Oncology Drug Development (Select any three reports)

Request Sample Pages or Access via 1stOncology™

  • You can request Free Sample Pages to Target Atlas in Oncology Drug Development: Targeted Therapies.
    To find out more about Target Atlas in Oncology Drug Development: Targeted Therapies, please read the product description below.
    We also are happy to email you out free sample pages which contain screen shots and more information on the methodology behind the product.

    Did you know that Target Atlas in Oncology Drug Development: Targeted Therapies is part of the 1stOncology™ platform and can be accessed at no extra cost?

    1stOncology™ allows you to always stay on top of what is really going on in the world of cancer drug development and have an edge when it comes to Search & Evaluation, Indication Selection & Expansion, Target Scouting, First-in-Class analysis and much, much more.


    Or

Other selected research from the 'Oncology' category:


Peptides in Oncology: Analytical Tool
This Analytical Tool transforms your computer’s desktop into a high capacity workbench within the area of peptides. It supports you in making reports, presentations and preparing conference attendance and it is all done via an easy to use ’point and click’ interface. Learn More


Triple Analysis: Prostate Cancer, Angiogenesis and Peptides
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Angiogenesis) and one compound specific area (Peptides). Learn More

Other selected research from the 'Targeted' category:


Cancer Antibodies: Competitive Positioning for Success
This report is written for you to identify your competition and understand which targeting strategies are at work within antibody drug development. It allows you to pin-point which competitors drugs’ clinical out-come may have bearing on your own drug development and who are developing sequels to blockbuster drugs. This report also helps you to locate white-spots in the competitive landscape, giving you little or no competition. Conversely it may reveal unexpected competition for you. Learn More


Lymphoma - A Therapeutic & Competitive Insight
Gain insight into the current challenges and commercial opportunities associated with lymphoma therapy Learn More